Bio Impact Capital LLC Dyne Therapeutics, Inc. Transaction History
Bio Impact Capital LLC
- $511 Million
- Q2 2025
A detailed history of Bio Impact Capital LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 1,446,361 shares of DYN stock, worth $18.6 Million. This represents 2.7% of its overall portfolio holdings.
Number of Shares
1,446,361Holding current value
$18.6 Million% of portfolio
2.7%Shares
1 transactions
Others Institutions Holding DYN
# of Institutions
211Shares Held
122MCall Options Held
36.5KPut Options Held
74.3K-
Ra Capital Management, L.P. Boston, MA9.71MShares$125 Million2.02% of portfolio
-
Janus Henderson Group PLC London, X09.44MShares$121 Million0.05% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$117 Million19.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.65MShares$98.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$95 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $666M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...